{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:01:34Z","timestamp":1791608494638,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Public Health Service Grant\/Cooperative Agreement","award":["5U24CA076518"],"award-info":[{"award-number":["5U24CA076518"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["4U10HL069294"],"award-info":[{"award-number":["4U10HL069294"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250201200016C"],"award-info":[{"award-number":["HHSH250201200016C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-17-1-2388"],"award-info":[{"award-number":["N00014-17-1-2388"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N0014-17-1-2850"],"award-info":[{"award-number":["N0014-17-1-2850"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Actinium Pharmaceuticals, Inc."},{"DOI":"10.13039\/100002429","name":"Amgen, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Amneal Biosciences"},{"DOI":"10.13039\/100016316","name":"Angiocrine Bioscience, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016316","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016253","name":"Atara Biotherapeutics, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016253","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001738","name":"Be The Match Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016508","name":"bluebird bio, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016508","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bristol Myers Squibb Oncology"},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016318","name":"Cerus Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016318","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100016875","name":"Chimerix, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016875","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gamida Cell Ltd."},{"DOI":"10.13039\/100005564","name":"Gilead Sciences, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HistoGenetics, Inc."},{"name":"Immucor"},{"name":"Incyte Corporation"},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014561","name":"Juno Therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014561","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007136","name":"Karyopharm Therapeutics, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007136","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kite Pharma, Inc."},{"DOI":"10.13039\/501100014841","name":"Medac, GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Medical College of Wisconsin"},{"name":"Mediware"},{"name":"Merck & Co, Inc."},{"name":"Mesoblast; MesoScale Diagnostics, Inc."},{"name":"Millennium"},{"DOI":"10.13039\/100011957","name":"Takeda Oncology Co.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Miltenyi Biotec, Inc."},{"name":"National Marrow Donor Program"},{"name":"Neovii Biotech NA, Inc."},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Otsuka Pharmaceutical Co, Ltd. \u2013 Japan"},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pfizer, Inc"},{"name":"Pharmacyclics, LLC"},{"name":"PIRCHE AG"},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010293","name":"Seattle Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spectrum Pharmaceuticals, Inc."},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015234","name":"Sunesis Pharmaceuticals, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015234","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Orphan Biovitrum, Inc."},{"DOI":"10.13039\/100011957","name":"Takeda Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017070","name":"Telomere Diagnostics, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017070","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bbmt.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T02:46:18Z","timestamp":1518576378000},"page":"1049-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":171,"title":["Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most"],"prefix":"10.1016","volume":"24","author":[{"given":"Bronwen E.","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent R.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.E.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Maiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Dehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Haagenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie W.","family":"Petersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Verneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Fleischhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbmt.2018.02.006_bib0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bbmt.2018.02.006_bib0015","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2018.02.006_bib0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2016.352","article-title":"Recipient\/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants","volume":"52","author":"Shaw","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bbmt.2018.02.006_bib0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbmt.2010.09.012","article-title":"HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation","volume":"17","author":"Woolfrey","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bbmt.2018.02.006_bib0030","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbmt.2018.02.006_bib0035","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3324\/haematol.2015.125294","article-title":"Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy","volume":"100","author":"Nakasone","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.bbmt.2018.02.006_bib0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbmt.2013.05.020","article-title":"Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation","volume":"19","author":"Morishima","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"10.1016\/j.bbmt.2018.02.006_bib0045","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbmt.2018.02.006_bib0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu364","article-title":"Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation","volume":"59","author":"Ljungman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.bbmt.2018.02.006_bib0055","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2013-02-481945","article-title":"Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3\/4\/5 associate with adverse outcomes in hematopoietic stem cell transplantation","volume":"121","author":"Fernandez-Vina","year":"2013","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.bbmt.2018.02.006_bib0060","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2013-02-482547","article-title":"High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis","volume":"122","author":"Furst","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bbmt.2018.02.006_bib0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"issue":"16","key":"10.1016\/j.bbmt.2018.02.006_bib0070","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","article-title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","volume":"124","author":"Pidala","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bbmt.2018.02.006_bib0075","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1182\/blood-2007-06-095265","article-title":"The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation","volume":"110","author":"Shaw","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbmt.2018.02.006_bib0080","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2017-03-742346","article-title":"HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities","volume":"130","author":"Fleischhauer","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.02.006_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2017.00041","article-title":"Reduction of relapse after unrelated donor stem cell transplantation by KIR-Based Graft Selection","volume":"8","author":"Heidenreich","year":"2017","journal-title":"Front Immuno"},{"issue":"14","key":"10.1016\/j.bbmt.2018.02.006_bib0090","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bbmt.2018.02.006_bib0095","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbmt.2005.07.015","article-title":"ABO blood group barrier in allogeneic bone marrow transplantation revisited","volume":"11","author":"Seebach","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.02.006_bib0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbmt.2014.10.017","article-title":"The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation","volume":"21","author":"Crivello","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bbmt.2018.02.006_bib0105","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.bbmt.2015.05.028","article-title":"HLA mismatch is associated with worse outcomes after unrelated donor reduced-intensity conditioning hematopoietic cell transplantation: an analysis from the center for international blood and marrow transplant research","volume":"21","author":"Verneris","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bbmt.2018.02.006_bib0110","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/bmt.2013.14","article-title":"Donor choice according to age for allo-SCT for AML in complete remission","volume":"48","author":"Ayuk","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2018.02.006_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1705195","article-title":"Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia","volume":"37","author":"Carreras","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2018.02.006_bib0120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/leu.2012.210","article-title":"Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings","volume":"27","author":"Kroger","year":"2013","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bbmt.2018.02.006_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/bmt.2016.201","article-title":"Sixty as the new forty: considerations on older related stem cell donors","volume":"52","author":"Anderlini","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.bbmt.2018.02.006_bib0130","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.pbio.0050201","article-title":"Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation","volume":"5","author":"Chambers","year":"2007","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1016\/j.bbmt.2018.02.006_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MOH.0b013e3283623c77","article-title":"Aging of the hematopoietic system","volume":"20","author":"Snoeck","year":"2013","journal-title":"Curr Opin Hematol"},{"issue":"26","key":"10.1016\/j.bbmt.2018.02.006_bib0140","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"5271","key":"10.1016\/j.bbmt.2018.02.006_bib0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.bbmt.2018.02.006_bib0150","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood.V96.13.4096","article-title":"Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program","volume":"96","author":"Davies","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bbmt.2018.02.006_bib0155","first-page":"1562","article-title":"The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors","volume":"90","author":"Shaw","year":"2005","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.bbmt.2018.02.006_bib0160","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1182\/blood-2012-08-453860","article-title":"Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?","volume":"121","author":"Alousi","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbmt.2018.02.006_bib0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bst0310457","article-title":"Centenarians as a model for healthy aging","volume":"31","author":"Franceschi","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"10.1016\/j.bbmt.2018.02.006_bib0170","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"26","key":"10.1016\/j.bbmt.2018.02.006_bib0175","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2014-09-599969","article-title":"HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation","volume":"124","author":"Petersdorf","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bbmt.2018.02.006_bib0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1500140","article-title":"High HLA-DP expression and graft-versus-host disease","volume":"373","author":"Petersdorf","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bbmt.2018.02.006_bib0185","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/trf.13509","article-title":"Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield","volume":"56","author":"Anthias","year":"2016","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.bbmt.2018.02.006_bib0190","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1111\/trf.12720","article-title":"Female donors and donors who are lighter than their recipient are less likely to meet the CD34+ cell dose requested for peripheral blood stem cell transplantation","volume":"54","author":"Billen","year":"2014","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.bbmt.2018.02.006_bib0195","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/trf.13239","article-title":"Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors","volume":"55","author":"Teipel","year":"2015","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bbmt.2018.02.006_bib0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2009.01.017","article-title":"Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant","volume":"15","author":"Lazarus","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.02.006_bib0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/bmt.2012.54","article-title":"Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision","volume":"48","author":"Lown","year":"2013","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118300843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118300843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:01:59Z","timestamp":1761058919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118300843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1083879118300843"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}